342 related articles for article (PubMed ID: 19758191)
41. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus.
Mandel M; Gurevich M; Pauzner R; Kaminski N; Achiron A
Clin Exp Immunol; 2004 Oct; 138(1):164-70. PubMed ID: 15373920
[TBL] [Abstract][Full Text] [Related]
42. Upregulated BclG(L) expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus.
Luo N; Wu Y; Chen Y; Yang Z; Guo S; Fei L; Zhou D; Yang C; Wu S; Ni B; Hao F; Wu Y
Clin Immunol; 2009 Sep; 132(3):349-61. PubMed ID: 19524489
[TBL] [Abstract][Full Text] [Related]
43. Efficiency of the DNA repair and polymorphisms of the XRCC1, XRCC3 and XRCC4 DNA repair genes in systemic lupus erythematosus.
Bassi C; Xavier Dj; Palomino G; Nicolucci P; Soares C; Sakamoto-Hojo E; Donadi E
Lupus; 2008 Nov; 17(11):988-95. PubMed ID: 18852222
[TBL] [Abstract][Full Text] [Related]
44. Immunoglobulin V-lambda transcription profiling of systemic lupus erythematosus patients reveals biased usage of genes located near the Jlambda-Clambda segments.
Trevisan GL; Tamia-Ferreira MC; Junta CM; Passos GA
Scand J Immunol; 2004 Apr; 59(4):395-9. PubMed ID: 15049783
[TBL] [Abstract][Full Text] [Related]
45. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
46. [Peripheral blood leukocyte double strand RNA-dependent protein kinase gene expression in patients with systemic lupus erythematosus].
Li M; Liang Y; Yu WJ; Wu XH; Sha H; Huang XY
Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):855-8. PubMed ID: 23291021
[TBL] [Abstract][Full Text] [Related]
47. Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus.
Andersen T; Munthe-Fog L; Garred P; Jacobsen S
J Rheumatol; 2009 Apr; 36(4):757-9. PubMed ID: 19208603
[TBL] [Abstract][Full Text] [Related]
48. T cell abnormalities in systemic lupus erythematosus.
Takeuchi T; Tsuzaka K; Abe T; Yoshimoto K; Shiraishi K; Kameda H; Amano K
Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
[TBL] [Abstract][Full Text] [Related]
49. A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus.
Dai Y; Hu C; Huang Y; Huang H; Liu J; Lv T
Lupus; 2008 Sep; 17(9):799-804. PubMed ID: 18755861
[TBL] [Abstract][Full Text] [Related]
50. Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray.
Zhang X; Lin P; Zhu ZH; Long H; Wen J; Yang H; Zhang X; Wang DF; Fu JH; Fang Y; Rong TH
Cancer Genet Cytogenet; 2009 Oct; 194(1):23-9. PubMed ID: 19737650
[TBL] [Abstract][Full Text] [Related]
51. Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.
Argos M; Kibriya MG; Parvez F; Jasmine F; Rakibuz-Zaman M; Ahsan H
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1367-75. PubMed ID: 16835338
[TBL] [Abstract][Full Text] [Related]
52. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
Satoh J; Nakanishi M; Koike F; Onoue H; Aranami T; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Saito T; Ohta M; Miyake S; Kanda T; Fukazawa T; Yamamura T
J Neuroimmunol; 2006 May; 174(1-2):108-18. PubMed ID: 16564577
[TBL] [Abstract][Full Text] [Related]
53. Overlapping BXSB congenic intervals, in combination with microarray gene expression, reveal novel lupus candidate genes.
Haywood ME; Rose SJ; Horswell S; Lees MJ; Fu G; Walport MJ; Morley BJ
Genes Immun; 2006 Apr; 7(3):250-63. PubMed ID: 16541099
[TBL] [Abstract][Full Text] [Related]
54. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
55. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive analysis of transcription factor expression patterns in peripheral blood mononuclear cell of systemic lupus erythematosus.
Sui W; Lin H; Chen J; Ou M; Dai Y
Int J Rheum Dis; 2012 Apr; 15(2):212-9. PubMed ID: 22462426
[TBL] [Abstract][Full Text] [Related]
57. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
58. Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes.
Chaussabel D; Allman W; Mejias A; Chung W; Bennett L; Ramilo O; Pascual V; Palucka AK; Banchereau J
Ann N Y Acad Sci; 2005 Dec; 1062():146-54. PubMed ID: 16461797
[TBL] [Abstract][Full Text] [Related]
59. The clinical characterisation of systemic lupus erythematosus in a Far North Queensland Indigenous kindred.
Mason JA; Bossingham D
Lupus; 2009 Feb; 18(2):144-8. PubMed ID: 19151116
[TBL] [Abstract][Full Text] [Related]
60. Genomic view of systemic autoimmunity in MRLlpr mice.
Liu J; Karypis G; Hippen KL; Vegoe AL; Ruiz P; Gilkeson GS; Behrens TW
Genes Immun; 2006 Mar; 7(2):156-68. PubMed ID: 16508641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
